Latest news
Bioelectric Therapy Enters Pivotal Trial for Dry AMD, suggests study - Medical DialoguesMedical Dialogues · Mon, 10 Aug 2026 15:15:33 GMTInsilico Medicine nominates AI-designed candidate for ocular diseases - Drug Target ReviewDrug Target Review · Mon, 10 Aug 2026 13:19:11 GMTAn AI Drug Company Named a Candidate for Dry Macular Degeneration, and the Target Is Undisclosed - Medical DailyMedical Daily · Fri, 07 Aug 2026 11:40:26 GMTNoninvasive bioelectric therapy for dry AMD begins pivotal study - HealioHealio · Fri, 07 Aug 2026 07:00:00 GMTNovel mechanisms reshaping the phase 3 pipeline in wet and dry AMD | Eye Care Network - Modern Retina - Ophthalmology Times EuropeOphthalmology Times Europe · Thu, 06 Aug 2026 19:26:56 GMTInsilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and Aging - Insilico MedicineInsilico Medicine · Thu, 06 Aug 2026 09:47:23 GMTPC Motherboards Are Now More Expensive, With ASUS Bumping Up Both AMD & Intel Lineups As PCB Supply Runs Dry - WccftechWccftech · Thu, 06 Aug 2026 06:30:14 GMTStudy Shows Dry iAMD Light Therapy is Cost-Effective - Review of OptometryReview of Optometry · Thu, 30 Jul 2026 17:56:10 GMT